Answers are grounded in this paper and cite their sources.
Mucopolysaccharidosis (MPS) is a rare, heterogeneous, and inherited disorder caused by a deficiency in the lysosomal enzyme called alpha-L-iduronidase. There is limited literature on the audiological manifestations in MPS type 1 and the practical problems associated with the condition. The report describes a 5-year-old boy diagnosed with MPS type 1 with multiple comorbidities. As the audiological manifestations associated with this disorder are unclear, an audiological test battery was administered. Tests such as behavioral threshold estimation, immittance audiometry, auditory brainstem responses, and distortion product otoacoustic emissions, were used to understand the auditory clinical manifestations of MPS type 1. The detailed investigation revealed severe to profound sensorineural hearing loss. The suggested treatment options, along with a review of the literature, are also discussed. The report highlights the importance of a comprehensive test battery approach in diagnosing such difficult-to-test cases with multiple coexisting conditions. The report also highlights the urgent need to improve healthcare access – both in terms of availability and affordability, especially for people dwelling in rural areas and belonging to the lower socioeconomic class, with rare but disabling conditions such as in the current case.
No takes yet. Share an insight, caveat, or question.
Dharani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: